trial · primary record
Giredestrant
Early Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1500 |
| Primary completion | 2032-11-30 |
| Primary endpoint | Incidence of Participants who Have Discontinued Giredestrant for any Reason |
| Registry ID | NCT07827573 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:50.036Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07827573
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Giredestrant · compound